CALC Strangle Strategy

CALC (CalciMedica, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

CalciMedica, Inc., a clinical-stage biotechnology company, focuses on developing therapies for life-threatening inflammatory diseases with unmet needs. Its proprietary technology targets the inhibition of calcium release-activated (CRAC) channels designs to modulate the immune response and protect against tissue cell injury in life-threatening inflammatory diseases. Its lead product candidate is Auxora, a proprietary intravenous-formulated CRAC channel inhibitor for the treatment of acute pancreatitis, asparaginase-associated acute pancreatitis, and acute kidney injury. The company is based in La Jolla, California.

CALC (CalciMedica, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $10.9M, a beta of 1.03 versus the broader market, a 52-week range of 0.461-7.2, average daily share volume of 307K, a public-listing history dating back to 2023, approximately 14 full-time employees. These structural characteristics shape how CALC stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.03 places CALC roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.

What is a strangle on CALC?

A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.

Current CALC snapshot

As of May 15, 2026, spot at $0.67, ATM IV 199.10%, expected move 57.08%. The strangle on CALC below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 63-day expiry.

Why this strangle structure on CALC specifically: IV rank is unavailable in the current snapshot, so regime-based timing for CALC is inferred from ATM IV at 199.10% alone, with a market-implied 1-standard-deviation move of approximately 57.08% (roughly $0.38 on the underlying). The 63-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CALC expiries trade a higher absolute premium for lower per-day decay. Position sizing on CALC should anchor to the underlying notional of $0.67 per share and to the trader's directional view on CALC stock.

CALC strangle setup

The CALC strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CALC near $0.67, the first option leg uses a $0.70 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CALC chain at a 63-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CALC shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$0.70	N/A
Buy 1	Put	$0.64	N/A

CALC strangle risk and reward

Net Premium / Debit: N/A
Max Profit (per contract): Unbounded
Max Loss (per contract): Unbounded
Breakeven(s): None on modeled curve
Risk / Reward Ratio: N/A

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.

CALC strangle payoff curve

Modeled P&L at expiration across a range of underlying prices for the strangle on CALC. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use strangle on CALC

Strangles on CALC are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the CALC chain.

CALC thesis for this strangle

The market-implied 1-standard-deviation range for CALC extends from approximately $0.29 on the downside to $1.05 on the upside. A CALC long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. As a Healthcare name, CALC options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CALC-specific events.

CALC strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CALC positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CALC alongside the broader basket even when CALC-specific fundamentals are unchanged. Always rebuild the position from current CALC chain quotes before placing a trade.

Frequently asked questions

What is a strangle on CALC?: A strangle on CALC is the strangle strategy applied to CALC (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With CALC stock trading near $0.67, the strikes shown on this page are snapped to the nearest listed CALC chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are CALC strangle max profit and max loss calculated?: Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the CALC strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 199.10%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a CALC strangle?: The breakeven for the CALC strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current CALC market-implied 1-standard-deviation expected move is approximately 57.08%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a strangle on CALC?: Strangles on CALC are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the CALC chain.
How does current CALC implied volatility affect this strangle?: Current CALC ATM IV is 199.10%; IV rank context is unavailable in the current snapshot.